EE351 Estimated Annual Treatment Cost of Hemophilia A Prophylaxis in the United States: Comparison of Jivi® with the Other Extended Half Life (EHL) Factor VIII Products

Abstract

Authors

J Malacan R Farej O Topachevskyi

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×